A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria
Joint Authors
Hasan, Osamah
Patel, Ankit A.
Siegert, James J.
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-02-24
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Recreational use of synthetic cannabinoids (SCs), also known as “K2” or “Spice,” is becoming a major public-health concern due to their potential for abuse and harmful consequences.
New substances are constantly being added to the content of SCs.
The dearth of information on these newly added contents as they are introduced into the black market hinders risk assessments of these compounds.
We report a highly unusual case of gross hematuria in a 28-year-old male patient after SC use.
He was found to have a supratherapeutic INR with no history of prior anticoagulation.
His hematuria resolved after four units of fresh-frozen plasma were administered.
We include a literature review of the clinical effects of SCs and their possible mechanism of gross hematuria and management.
American Psychological Association (APA)
Hasan, Osamah& Patel, Ankit A.& Siegert, James J.. 2019. A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria. Case Reports in Medicine،Vol. 2019, no. 2019, pp.1-3.
https://search.emarefa.net/detail/BIM-1140946
Modern Language Association (MLA)
Hasan, Osamah…[et al.]. A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria. Case Reports in Medicine No. 2019 (2019), pp.1-3.
https://search.emarefa.net/detail/BIM-1140946
American Medical Association (AMA)
Hasan, Osamah& Patel, Ankit A.& Siegert, James J.. A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria. Case Reports in Medicine. 2019. Vol. 2019, no. 2019, pp.1-3.
https://search.emarefa.net/detail/BIM-1140946
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1140946
